In Vivo Scientist, pharmacology

Minerva Imaging, Oelstykke, Denmark


Minerva Imaging is a fast growing, entrepreneurial and scientifically driven CRO with the ambition to be the globally leading CRO in our areas of expertise. To facilitate the continued growth, we seek a dedicated and skilled in vivo scientist to join our in vivo pharmacology team working closely with our collaborators developing novel cancer radiopharmaceuticals.


Your role

You will work in a cross-functional and fast-paced environment delivering study results and high-quality data for our collaborators. You will be part of our pharmacology team and your main tasks will be to plan and execute in vivo pharmacology projects for our collaborators. The work includes coordination and conduct of scientific studies in collaboration with our skilled technicians by data collection, data analysis and reporting to ongoing communication with external collaborators and with the team. You will primarily be involved as a Study Director on collaborator projects, but you will also be involved as a team member in other projects. Introduction and training will be a natural part of the onboarding process and tailored to match the right candidate.

You will be responsible for providing expert contribution to the in vivo pharmacology capabilities at Minerva Imaging, support our continued development and setup of advanced in vivo cancer models and help to extend our range of services within evaluation of cancer radiopharmaceuticals.

The ideal candidate takes ownership, is proactive and sets high quality standards for data deliveries. It is essential that you have a positive attitude and enjoy working with changing priorities, deadlines and shifts between laboratory and office work.


Key Responsibilities

  • Design, plan and execute external and internal research activities within oncology
  • Study-related tasks including contact to collaborators, protocol writing, data handling and analysis, reporting and presentation of data
  • Involvement in setup and establishment of relevant animal models primarily within oncology in collaboration with academic partners and external collaborators
  • Provide expert pharmacology knowhow and feedback
  • Participation in development of our portfolio, including support to identification of new areas of interest for us and our collaborator


Your profile

To succeed in this position, you should hold a master’s degree within natural or life sciences and/or a PhD combined with:

  • Relevant hands-on experience preferably with in vivo cancer models and evaluation of cancer therapies
  • Prior experience with radiopharmaceuticals and molecular imaging such as PET/CT or SPECT/CT is a strong advantage
  • Clear understanding of molecular methods such as qPCR, immunohistochemistry and flow cytometry. Experience with flow cytometry and cell-based assays is a plus
  • Quality and detail-oriented mindset and excellent data presentation and analysis skills
  • Ability to drive projects on your own and thrive working with tight deadlines
  • Excellent English communication skills, both written and oral


On a personal note you are

  • A proactive communicator and team-player
  • Enthusiastic and passionate, but keeps attention to detail
  • Problem-solving and have strong analytical skills
  • Ability to thrive in a fast paced, dynamic, service organization where our collaborators rely on our ability to run the extra mile


As we are an informal organization, we value humor and a natural care for one another, meaning stepping up and lending a helping hand to a colleague when needed, and we keep focus on open and honest communication.

If this sounds like you, please submit your application no later than March 20, 2021 to The application must include a motivated cover letter and a CV addressing the listed qualifications.

If you have questions regarding the position, please contact: In Vivo Pharmacology Group Leader, Lotte Kellemann Kristensen; email:

Applications will be evaluated continuously, and we will invite potential applicants for job interview accordingly.


About Minerva Imaging

Minerva Imaging is a scientifically driven CRO founded in 2011 approaching 50 employees. Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development. We engage with our collaborators to understand their scientific questions and discuss how our methods and capabilities can provide answers. We are rapidly growing, and the right candidate will be a key contributor to maintaining the scientific foundation and our approach to research, while expanding our business. You will join a highly specialized CRO, with ambitions of taking disease treatment to the next generation of personalized medicines.